DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Echo Health Ventures LLC
Echo Health Ventures LLC
Corporate venture · probablePortland, ORechohealthventures.comSEC exempt reporting adviserpart of Echo Health Ventures
One of 2 advisers that share echohealthventures.com; the firm is Echo Health Ventures. Echo Health Ventures LLC. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
corporate parent: Regence Insurance Holding Corporation
Importance
0
low
Active deployment
4
low
Emerging
0
low
Completeness
31
moderate
Freshness
97
high
Research priority
1
low
Identity and regulatory footprint
- Headquarters
- Portland, ORadviserinfo.sec.gov
- Office address
- 100 SW MARKET STREET, M/S E15B, Portland, OR, 97201-5723adviserinfo.sec.gov
- Business phone
- 503-220-6146adviserinfo.sec.gov
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Mar 31, 2021
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $4.0Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Cambia Health Solutions, Inc. (Sole Member), E; Noblehealth, Inc. (Sole Member), E; Regence Insurance Holding Corporation (Sole Member), E; Mosaic Health Solutions, LLC (Member), D; Cascadia Echo Holding Company LLC (Member), D; Blue Cross Blue Shield of North Carolina (Sole Shareholder), E
- business phone
- 503-220-6146adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
- Sectors
- not stated or not yet read
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series a 100%
Stage at first entry
series a 100%
Sectors
Other Health Care 100%
lead rate 0%follow-on rate 0%new logos, 12 months 1
Funds and vehicles
0 reported
No vehicle on record yet. A fund arrives from Form ADV Schedule D 7.B.(1) or a Form D filing.
Investment team
7 current, 2 departed
Gerald Allan Petkau
Board or advisoryMember Of The Board Of Directors And The Investment Committee · since Sep 1, 2019
Jeffrey Thompson Barber
Board or advisoryMember Of The Board Of Directors · since Nov 1, 2016
Luis F Machuca
Board or advisoryMember Of The Board Of Directors · since Nov 1, 2016
Mark Burns Ganz
Board or advisoryMember Of The Board Of Directors And The Investment Committee · since Nov 1, 2016
Michael Gary Koppel
Board or advisoryMember Of The Board Of Directors · since Nov 1, 2016
Roberta Bromberg Bowman
Board or advisoryMember Of The Board Of Directors · since Nov 1, 2016
Robert Matthew Coppedge
Founder or executiveChief Executive Officer And Member Of The Investment Committee · since Nov 1, 2016
2 departed (kept with end dates)
- James Bradley Wilson · Member Of The Board Of Directors And The Investment Committee · Nov 1, 2016 to Mar 31, 2018 Inference
- Patrick Hugh Conway · Member Of The Board Of Directors And The Investment Committee · Oct 1, 2017 to Apr 1, 2020 Inference
Investments on record
1 edges, 1 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Optura, Inc. | Series A · Series A | participant | unknown | $17.5M | unknown | May 14, 2026 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
12 relationships from shared deals, counted for the whole firm
Ascension Ventures 1 shared · one timeNEA: New Enterprise Associates 1 shared · one timeOCA Ventures, LLC 1 shared · one time6th Man Ventures, LLC 1 shared · one timeSJF Management LLC 1 shared · one timeHLM Management Co., LLC 1 shared · one timeWayfinder Ventures Management, L.L.C. 1 shared · one timeQuesta Capital Management, L.L.C. 1 shared · one timeLerer Hippeau Ventures Management, LLC 1 shared · one timeRCJ Ventures Management, LLC 1 shared · one timeSalesforce Ventures 1 shared · one time · they led 1Matrix 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
6 dated events
- Apr 1, 2020Patrick Hugh Conway (Member Of The Board Of Directors And The Investment Committee) no longer on Schedule A of Echo Health Ventures LLC
- Sep 1, 2019Gerald Allan Petkau joined Schedule A of Echo Health Ventures LLC as Member Of The Board Of Directors And The Investment Committee
- Mar 31, 2018James Bradley Wilson (Member Of The Board Of Directors And The Investment Committee) no longer on Schedule A of Echo Health Ventures LLC
- Oct 1, 2017Patrick Hugh Conway joined Schedule A of Echo Health Ventures LLC as Member Of The Board Of Directors And The Investment Committee
- Jul 21, 2017Echo Health Ventures LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jul 21, 2017Echo Health Ventures LLC first reported on Form ADV by Echo Health Ventures LLC (Venture Capital Fund), GAV $200,000,000Fund first reported on Form ADVFundsFactEcho Health Ventures LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Corporate venture (probable, 80%, cls-1)corporate parent: Regence Insurance Holding Corporation
Evidence
18 observations from 1 source